Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Home Depot Inc (HD) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Home Depot IncTrade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Home Depot Inc vs IDEXX Laboratories, Inc. — how do they compare? Home Depot Inc trades at $329.07 (market cap $332.08B), while IDEXX Laboratories, Inc. trades at $558.86 (market cap $44.48B). The key difference: Home Depot Inc is far larger — about 7.5× IDEXX Laboratories, Inc.'s market cap, and Home Depot Inc pays a 2.8% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.

HDIDXX
Market Cap
$332.08B$44.48B
Sector
Consumer CyclicalHealth
52-Week High
$423.42$766.68
52-Week Low
$297.51$520.87
Enterprise Value
$393.64B$45.38B
Dividend Yield
2.8%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Home Depot Inc

Home Depot (HD) trades at $329.29, down 2.83% over 24 hours, with a bearish technical signal and near-term support at $328. The stock shows strong profitability with a net margin of 8.41% and ROE of 128.38%, though revenue growth is modest and net income has declined from $16.4B in 2022 to $14.8B in 2025. Recent earnings beat expectations in Q4 2025 and Q1 2026, but Q3 2025 was a miss. Analyst consensus is bullish with a $370.59 price target, but weakening housing demand and margin pressures pose risks.

HD offers a solid long-term investment case driven by professional segment growth and housing tailwinds, supported by a 59% buy rating from analysts. However, near-term headwinds include rising mortgage rates impacting big-ticket sales, competitive pressures, and high debt levels. The stock's current valuation at a P/E of 23.65 appears reasonable if earnings stabilize, but investors should monitor housing market trends and quarterly execution for sustained upside.

IDEXX Laboratories, Inc.

IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.

Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.

Returns comparison

Trailing returns across standard periods

About Home Depot Inc

Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.

Read more on HD

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX